News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

First patient dosed in Phase 1 Trial

Oct 23rd 2023
Iksuda Therapeutics announces first patient dosed in Phase 1 trial of IKS014 in patients with advanced solid tumours that express HER2
Read More

PharmaKure Announces Successful Scientific Advice Meeting with the MHRA

Feb 6th 2023
With approval of MHRA to submit a CTA, PharmaKure is now well positioned to advance towards its clinical trial programme that is essential to market authorisation
Read More

Identifying novel inhibitors against tuberculosis

Nov 3rd 2022
Using the active site to generate new designs for InhA reductase inhibitors
Read More

Grant Opportunities in Life Science Sector

Jun 24th 2021
The Markel Grants Team provide expert support in writing and securing funding for new product development. Markel have partnered with Bionow for several years, providing expert support and a...
Read More

Government funding boost for COVID-19 drug testing platform

Feb 16th 2021
The COVID-19 drug testing platform AGILE, co-led by the University of Liverpool, has received a multi-million pound award from the UK government’s Department of Health and Social Care to f...
Read More

Artificial intelligence-supported early fracture diagnosis: SBRI competition

Jun 3rd 2019
Organisations can apply for a share of £240,000, including VAT, to develop an innovative AI solution for radiological diagnosis of fractures of upper and/or lower limbs
Read More

Blueberry Therapeutics Announce Positive Results from a Phase I/II Clinical Tria...

Nov 26th 2018
Blueberry Therapeutics Limited, a modern drug discovery and development company committed to the development of innovative new therapies for the treatment of common and difficult to treat de...
Read More

Quay devises bespoke filling system for drug delivery treatment of gastrointesti...

May 21st 2018
Quay Pharma has developed a specialised filling system to enable a new treatment for anorectal diseases to enter Phase 3 clinical trials.
Read More

Search Site

  Latest Jobs

Sign up to our Newsletter

Our Valued Sponsors & Partners